POHJOIS-POHJANMAAN HYVINVOINTIALUE

Their core work

POHDE (North Ostrobothnia Wellbeing Services County) is the public authority responsible for healthcare and social services across the Oulu region in northern Finland, including the Oulu University Hospital (OYS), one of Finland's five university hospitals. In EU research, they function as a real-world clinical deployment site — providing patient populations, hospital infrastructure, clinical workflows, and operational validation environments that research consortia cannot replicate in a lab. Their participation in AICCELERATE positions them as an early adopter of AI-driven hospital care pathway optimization, integrating machine learning tools directly into live surgical, emergency, and discharge workflows. For technology developers and researchers, they represent a rare combination: a large regional health authority with both the institutional mandate and clinical scale to test, validate, and deploy digital health innovations.

What they specialise in

How they've shifted over time

In their earlier H2020 engagement (I4FUTURE, 2016–2021), POHDE's involvement centred on advanced imaging and materials characterisation — likely providing clinical context or infrastructure to a University of Oulu-led MSCA fellowship programme. By 2021, their focus shifted sharply toward operational AI: machine learning, robotics, patient flow optimisation, and clinical pathway automation across multiple hospital departments. This trajectory reflects a broader strategic move from passive research host to active digital health implementer — an organisation building internal capacity to run AI tools at scale rather than simply enabling others to study medicine nearby.

POHDE is moving toward becoming a reference site for AI-powered hospital operations in northern Europe — future collaborations are most relevant in clinical AI, predictive patient flow, and surgical decision-support tools that require large-scale hospital validation.

How they like to work

POHDE has not led any H2020 projects, consistently joining as a partner or participant — typical of a public health authority that contributes clinical infrastructure and operational expertise rather than driving research agendas. Despite only two projects, they have engaged with 41 distinct consortium partners, suggesting they participate in large, multi-partner Innovation Actions where their role is real-world deployment rather than research leadership. Working with them likely means access to a major Finnish university hospital environment, patient populations, and clinician networks, in exchange for co-design input and co-authorship on clinical outcomes.

Across just two projects, POHDE has built connections with 41 unique consortium partners spanning 13 countries — a breadth that reflects the large international consortia (particularly the 18-partner AICCELERATE project) rather than a long track record. Their network skews toward northern and western Europe, consistent with Horizon 2020 digital health consortia patterns.

What sets them apart

POHDE is one of the few Finnish regional health authorities with direct EU research project experience, giving them credibility and administrative capacity that most hospital-based partners lack. They bring Oulu University Hospital — a 900-bed tertiary care centre serving 400,000 people — as a validation environment, which is a meaningful asset for any consortium needing real-world clinical deployment at scale. For digital health technology developers, this means access to a real, high-volume northern European hospital willing to pilot and validate AI tools under live operational conditions.

Highlights from their portfolio

• AICCELERATE
  The largest-funded project for POHDE (EUR 624,250), this Innovation Action deployed AI care pathway engines across multiple hospital departments — making POHDE one of the few public health authorities in Finland actively running AI tools in live surgical and emergency settings.
• I4FUTURE
  An MSCA-COFUND fellowship programme connecting POHDE to advanced imaging and materials research, signalling early openness to interdisciplinary EU collaboration well before their digital health pivot.